BB BIOTECH AG CHF0.20 (REGD) - CH0038389992 (Stock)
/IBT-BA-HP/WEB-INF/snippets/root/general/name.jsp
0
0
0
42,50 USD
|
12,4636% |
04.02.2025 21:08
|
- |
- |
- |
- |
/IBT-BA-HP/WEB-INF/snippets/root/general/v2/infobar.jsp
0
0
0
/IBT-BA-HP/WEB-INF/snippets/root/general/toolbar.jsp
32
0
32
/IBT-BA-HP/WEB-INF/snippets/root/stock/navigation.jsp
1030
0
1030
Balance ratios |
2024 |
2023 |
Total assets |
2.407.399 CHF |
2.637.154 CHF |
Employees |
- |
- |
Cash and cash equivalents |
458 CHF |
501 CHF |
Intangible / inalienable assets |
0 CHF |
0 CHF |
Economic shareholder's equity |
2.286.292 CHF |
2.323.217 CHF |
Subscribed Capital |
11.080 CHF |
11.080 CHF |
Liabilities |
121.107 CHF |
313.937 CHF |
Liabilities to financial institutions |
- |
- |
GuV Zahlen |
2024 |
2023 |
Sales |
62.133 CHF |
-17.264 CHF |
Profit after tax |
75.899 CHF |
-206.607 CHF |
Deprecation (??) |
- |
- |
Dividend ordinary shares |
- |
- |
Net investment income |
0 CHF |
0 CHF |
Dividend preferred shares |
- |
- |
Net interests income |
-408 CHF |
-411 CHF |
Earnings from ordinary operating activities |
75.953 CHF |
-206.528 CHF |
Net income (after minority interests) |
75.899 CHF |
-206.607 CHF |
Net earnings per share |
1.38 CHF |
-3.77 CHF |
Total payout |
109.692 CHF |
156.311 CHF |
Administrative expenses |
- |
- |